Alleviation of behavioral deficits in aged rodents following implantation of encapsulated GDNF-producing fibroblasts

Brain Research

Volumn 736, Issue 1-2, 1996, Pages 99-110

  Emerich, Dwaine F ^a   Plone, Melissa ^a   Francis, Johnathan ^a   Frydel, Beata R ^a   Winn, Shelley R ^a   Lindner, Mark D ^a  

^a CytoTherapeutics Inc   (United States)

Author keywords

aging; behavior; dopamine; GDNF; polymer; striatum; transplant

Indexed keywords

NEURITE PROMOTING FACTOR; TYROSINE 3 MONOOXYGENASE;

ADOLESCENT; AGED; AGING; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BEHAVIOR; CELL TRANSPLANTATION; CONTROLLED STUDY; CORPUS STRIATUM; DOPAMINERGIC SYSTEM; FIBROBLAST; HISTOLOGY; LOCOMOTION; MALE; NONHUMAN; PRIORITY JOURNAL; RAT;

EID: 0030583639     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-8993(96)00683-X     Document Type: Article

References (72)

1. [1] Abrous, D.N. and Dunnett, S.B., Paw reaching in rats - The staircase test, In F.G. Wouterlood (Ed.), Neuroscience Protocols, Module 3, Elsevier, Amsterdam, 1994, pp. 19-29.
2. [2] Adolfsson, R., Gottfries, C.G., Roos, B.E. and Winblad, B., Postmortem distributions of dopamine and homovanillic acid in human brain, variation related to age, and a review of the literature, J. Neural Transm., 45 (1979) 81-105.
3. [3] Aebischer, P., Tresco, P.A., Winn, S.R., Greene, L.A. and Jaeger, C.B., Long-term cross-species brain transplantation of a polymer-encapsulated dopamine-secreting cell line, Exp. Neurol., 111 (1991) 269-275.
4. [4] Aebischer, P., Wahlberg, L., Tresco, P.A. and Winn, S.R., Macroencapsulation of dopamine-secreting cells by coextrusion with an organic polymer solution, Biomaterials, 12 (1991) 50-56.
5. [5] Barnes, C.A., Nadel, L. and Honig, W.K., Spatial memory deficit in senescent rats, Can. J. Psychol., 34 (1980) 29-39.
6. [6] Battaglia, G., Norman, A.B. and Creese, I., Age-related differential recovery rates of rat striatal D-1 dopamine receptors following irreversible inactivation, Eur. J. Pharmacol., 45 (1988) 281-290.
7. [7] Beck, K.D., Valverde, J., Alexi, T., Poulsen, K., Moffat, B., Vandlen, R.A., Rosenthal, A. and Hefti, F., Mesencephalic dopaminergic neurons protected by GDNF from axotomy-induced degeneration in the adult brain. Science, 373 (1995) 339-351.
8. [8] Bunsey, M.D. and Sanberg, P.R., The topography of the locomotor effects of haloperidol and domperidone, Behav. Brain Res., 19 (1986) 147-152.
9. [9] Cabasso, I., Hollow fiber membranes. In K. Othmer (Ed.) Encyclopedia of Chemical Technology., Vol 85, Wiley, New York, NY, 1980, pp. 492-517.
10. [10] Dodd, D.H. and Schultz, R.F., Jr., Computational procedures for estimating magnitude of effect for some analysis of variance designs, Psychol. Bull., 79 (1973) 391-395.
11. [11] Dunnett, S.B., Transplantation of embryonic dopamine neurons: what we know from rats, J. Neurol., 238 (1991) 65-74.
12. [12] Emerich, D.F., Winn, S.R., Christenson, L., Palmatier, M., Gentile, F.T. and Sanberg, P.R., A novel approach to neural transplantation in Parkinson's disease: Use of polymer-encapsulated cell therapy, Neurosci. Biobehav. Rev., 16 (1992) 437-447.
13. [13] Emerich, D.F., Frydel, B., McDermott, P., Krueger, P., Lavoie, M., Sanberg, P.R. and Winn, S.R., Polymer-encapsulated PC12 cells promote recovery of motor function in aged rats, Exp. Neurol., 122 (1993) 37-47.
14. [14] Emerich, D.F., Winn, S.R., Harper, J., Hammang, J.P., Baetge, E.E. and Kordower, J.H. Transplantation of polymer-encapsulated cells genetically modified to secrete human nerve growth factor prevents the loss of degenerating cholinergic neurons in nonhuman primates, J. Comp. Neurol., 349 (1994) 148-164.
15. [15] Emerich, D.F., Hammang, J.P., Baetge, E.E. and Winn, S.R., Implantation of polymer-encapsulated human nerve growth factor-secreting fibroblasts attenuates the behavioral and neuropathological consequences of quinolinic acid injections into rodent striatum. Exp. Neurol., 130 (1994) 141-150.
16. [16] Fischer, W., Gage, F.H. and Bjorklund, A., Degenerative changes in forebrain cholinergic nuclei correlate with cognitive impairments in aged rats, Eur. J. Neurosci., 1 (1989) 4-45.
17. [17] Freed, W.J., Substantia nigra grafts and Parkinson's disease: from animal experiments to human therapeutic trials, Restor. Neurol. Neurosci., 3 (1991) 109-134.
18. [18] Gage, F.H., Dunnett, S.B., Bjorklund, A. and Stenevi, U., Aged rats: recovery of motor coordination impairments by intrastriatal nigral grafts, Science, 221 (1983) 966-969.
19. [19] Gage, F.H., Dunnett, S.B. and Bjorklund, A., Spatial learning and motor deficits in aged rats, Neurobiol. Aging, 5 (1984) 43-48.
20. 3H-SCH 23390: Decrease in the striatum of aged rats, Neurobiol. Aging, 8 (1987) 51-54.
21. [21] Goldman-Rakic, P.S. and Brown, R.M., Regional changes of monoamines in cerebral cortex and subcortical structures of aging rhesus monkeys, Neuroscience, 6 (1981) 177-187.
22. 2-receptor-containing neurons in the rat striatum, Brain Res., 498 (1989) 299-307.
23. [23] Haycock, J.W., White, W.F., McGaugh, J.L. and Cotman, C.W., Enhanced stimulus-secretion coupling from brain of aged mice, Exp. Neurol., 57 (1977) 873-882.
24. [24] Henry, J.M. and Roth, G.S., Effect of aging on recovery of striatal dopamine receptors following N-ethoxycarbonyl-2-ethoxy-1,2-dihydroquinoline (EEDQ) blockade, Life Sci., 35 (1984) 899-904.
25. [25] Henry, J.M., Filburn, C.R., Joseph, J.A. and Roth, G.S., Effect of aging on striatal dopamine receptor subtypes in Wistar rats, Neurobiol. Aging, 7 (1986) 357-362.
26. [26] Hoffer, B.J., Hoffamn, A., Bowenkamp, K., Huettl, P., Hudson, J., Martin, D., Lin, L.H. and Gerhardt, G.A., Glial cell line-derived neurotrophic factor reverses toxin-induced injury to midbrain dopaminergic neurons in vivo, Neurosci. Lett., 182 (1994) 107-111.
27. [27] Hou, J-G. G., Lin, L-F.H. and Mytilineou, C., Glial cell line-derived neurotrophic factor exerts neurotrophic effects on dopaminergic neurons in vitro and promotes their survival and regrowth after damage by 1-methyl-4-phenylpyridinium, J. Neurochem., 66 (1996) 74-82
28. [28] Hytell, J., Parallel decrease in the density of dopamine D-1 and D-2 receptors in the corpus striatum of rats from 3 to 25 months of age, Pharmacol. Toxicol., 64 (1989) 55-57.
29. [29] Joseph, J.A., Bartus, R.T., Clody, D., Morgan, D., Finch, C., Beer, B. and Sesack, S., Psychomotor performance in the senescent rodent: Reduction of deficits via striatal dopamine receptor up-regulation, Neurobiol. Aging, 4 (1983) 313-319.
30. [30] Joseph, J.A. and Roth, G.S., Upregulation of striatal dopamine receptors and improvement of motor performance in senescence. In J.A. Joseph (Ed.), Central Determinants of Age-Related Declines in Motor Function, Vol. 515, Ann. N.Y. Acad. Sci. New York, NY, 1988 pp. 355-362,
31. [31] Kawaja, M.D., Fagan, A.M., Firestein, B.L. and Gage, F.H., Intracerebral grafting of cultured autologous skin fibroblasts into the rat striatum:an assessment of graft size and ultrastructure, J. Comp. Neurol., 307 (1991) 695-706.
32. [32] Kawaja, M.D., Rosenberg, M.B., Yoshida, K. and Gage, F.H., Somatic gene transfer of nerve growth factor promotes the survival of axotomized septal neurons and the regeneration of their axons in adult rats, J. Neurosci., 12 (1992) 2849-2864.
33. [33] Kirk, R.E. (1982) Experimental Design: Procedures for the Behavioral Sciences, Brooks/Cole Publishing Company, Pacific Grove, CA, 1986, pp. 230-235.
34. [34] Kolberg, R., Gene-transfer virus contaminant linked to monkeys' cancer, J. NIH Res., 12 (1992) 2849-2864.
35. [35] Kordower, J.H., Winn, S.R., Liu, Y-T., Mufson, E.J., Sladek, J.R. Jr., Baetge, E.E., Hammang, J.P. and Emerich, D.F., The aged monkey basal forebrain:rescue and sprouting of axotomized basal forebrain neurons after grafts of encapsulated cells secreting human nerve growth factor, Proc. Natl. Acad. Sci. USA, 91 (1994) 10898-10902.
36. [36] Kordower, J.H., Liu, Y-T., Winn, S.R. and Emerich, D.F., Encapsulated PC12 cell transplants into hemiparkinsonian monkeys: a behavioral, neuroanatomical and neurochemical analysis, Cell Trans., 4 (1995) 55-171.
37. [37] Kordower, J.H., Chen, E-Y., Mufson, E.J., Winn, S.R. and Emerich, D.F., Intrastriatal implants of polymer-encapsulated cells genetically modified to secrete human NGF:trophic effects upon cholinergic and noncholinergic neurons, Neuroscience, 72 (1996) 63-67.
38. [38] Lai, H., Bowden, D.M. and Horita, A., Age-related decreases in dopamine receptors in the caudate nucleus and putamen of the Rhesus monkey (Macaca mulatto), Neurobiol. Aging, 8 (1987) 45-49.
39. [39] Langston, J.W., Ballard, P., Tetrud, J.W. and Irwin, I., Chronic Parkinsonism in humans due to a product of meperidine analog synthesis, Science, 219 (1983) 979-980.
40. [40] Larson, L. and Ansved, T., Effects of age on the motor unit. In J.A. Joseph (Ed.), Central Determinants of Age-Related Declines in Motor Function, Vol. 515, Ann. N.Y. Acad. Sci. New York, NY, 1988, pp. 303-313.
41. [41] Lin, L.H., Doherty, D.H., Lile, J.D., Bektesh, S. and Collins, F., GDNF, a glial cell line-derived neurotrophic factor for midbrain dopaminergic neurons, Science, 260 (1993) 1130-1132.
42. [42] Lin, L-F.H., Zhang, T.J., Collins, F. and Armes, L.G., Purification and initial characterization of rat B49 glial cell line-derived neurotrophic factor, J. Neuroschem., 63 (1994) 758-768.
43. [43] Lindner, M.D., Winn, S.R., Baetge, E.E., Hammang, J.P., Gentile, F.T., Doherty, E., McDermott, P.E., Frydel, B., Ullman, M.D., Schallert, T. and Emerich D.F., Implantation of encapsulated catecholamine and GDNF-producing cells in rats with unilateral dopamine depletions and parkinsonian symptoms, Exp. Neurol., 132 (1995) 62-76.
44. [44] Lindner, M.D., Kearns, C.E., Winn, S.R., Frydel, B.R. and Emerich, D.F., Effects of intraventricular encapsulated hNGF-secreting fibroblasts in aged rats. Cell Trans., 5 (1996) 205-223.
45. [45] Makman, M.H., Ahn, H.S., Thal, L.J., Sharpless, N.S., Dvorkin, B., Horowitz, S.G. and Rosenfeld, M., Evidence for selective loss of dopamine-and histamine-stimulated adenylate cyclase activities in rabbits with aging, Brain Res., 192 (1980) 177-184.
46. [46] Marshall, J.F. and Berrios, N., Movement disorders of aged rats: reversal by dopamine receptor stimulation, Science, 206 (1979) 477-479.
47. [47] Martin, J.R., Fuchs, A. and Harting, J., Spontaneous activity in the senescent rat, Neurosci. Lett. (Suppl), 14 (1983) 236.
48. [48] McGeer, E.G. and McGeer, P.L., Age changes in the human for some enzymes associated with metabolism of catecholamines, GABA, and acetylcholine. In J.M. Ordy and K.R. Brizzee, (Eds.), Neurobiology of Aging, Plenum Press, New York, NY, 1975, pp. 287-305
49. 2 receptors during aging is partially due to decreased levels of mRNA, Brain Res., 545 (1991) 355-357.
50. [50] Montoya, C.P., Astell, S. and Dunnett, S.B., Effects of nigral and striatal grafts on skilled forelimb use in the rat, Prog. Brain Res., 82 (1990) 459-466.
51. [51] Montoya, C.P., Campbell-Hope, L.J., Pemberton, K.D. and Dunnett, S.B., The 'staircase test': a measure of independent forelimb reaching and grasping abilities in rats, J. Neurosci. Methods, 36 (1991) 219-228.
52. [52] Paxinos, G. and Watson, C., The Rat Brain in Stereotaxic Coordinates, Academic Press, San Diego, CA., 1986.
53. [53] Puri, S.K. and Volicer, L., Effects of aging on cyclic AMP levels and adenylate cyclase and phosphodiesterase activities in the rat corpus striatum, Mech. Aging Dev., 6 (1977) 53-58.
54. [54] Ricaurte, G.A., Irwin, I., Forno, L.S., Delanney, L.E., Langston, E. and Langston, J.W., Aging and 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced degeneration of dopaminergic neurons in the substantia nigra, Brain Res., 403 (1987) 43-51.
55. [55] Rogers, J., The neurobiology of cerebellar senescence. In J.A. Joseph, (Ed.), Central Determinants of Age-Related Declines in Motor Function, Vol. 515, Ann. N.Y. Acad. Sci. New York, NY, 1988, pp. 251-268.
56. [56] Salthouse, T.A., Cognitive aspects of motor functioning. In J.A. Joseph, (Ed.), Central Determinants of Age-Related Declines in Motor Function, Vol. 515. Ann. N.Y. Acad. Sci. New York, NY, 1988, pp. 33-41.
57. [57] Samorajski, T., Delaney, C., Durham, L., Ordy, J.M., Johnson, J.A. and Dunlap, W.P., Effect of exercise on longevity, body weight, locomotor performance, and passive-avoidance memory of C57BL/6J mice, Neurobiol. Aging, 6 (1985) 17-24.
58. [58] Sanberg, P.R., Henault, M.A., Hagenmeyer-Hauser, S.H. and Russell, K.H., The topography of amphetamine and scopolamine-induced hyperactivity: toward an activity print, Behav. Neurosci., 101 (1987) 131-133.
59. [59] SAS Institute Inc. SAS/STAT User's Guide, Version 6, 4th edn., Vol. 1, SAS Institute Inc., Cary, North Carolina, 1989.
60. [60] Schaar, D.G., Sieber, B.-A., Dreyfus, C.F. and Black, I.B., Regional and cell-specific expression of GDNF in rat brain, Exp. Neurol., 124 (1993) 368-371.
61. [61] Simpkins, J.W., Mueller, G.P., Huang, H.H. and Meites, J., Evidence for depressed catecholamine and enhanced serotonin metabolism in aging male rats: possible relation to gonadotropin secretion, Endocrinology, 100 (1978) 1672-1678.
62. [62] Stoessl, A.J., Martin-Iverson, M.T., Barth, T.M., Dourish, C.T. and Iverson, S.D., Effects of ageing on the behavioural reponses to dopamine agonists: decreased yawning and locomotion, but increased stereotypy, Brain Res., 495 (1989) 1-30.
63. [63] Stromberg, I., Bjorklund, A., Johansson, M., Tomac, A., Collins, F., Olson, L., Hoffer, B. and Humpfel, C., Glial cell line-derived neurotrophic factor is expressed in the developing but not adult striatum and stimulates developing dopamine neurons, Exp. Neurol., 124 (1993) 401-412.
64. [64] Tomac, A., Lindqvist, E., Lin, L-F.H., Ogren, S.O., Young, D., Hoffer, B.J. and Olson, L., Protection and repair of the nigrostriatal dopaminergic system by GDNF in vivo. Science, 373 (1995) 335-339.
65. [65] Tomac, A., Widenfalk, J., Lin, L-F.H., Kohno, T., Ebendal, T., Hoffer, B.J. and Olson, L., Retrograde axonal transport of glial cell line-derived neurotrophic factor in the adult nigrostriatal system suggests a role in the adult, Proc. Natl. Acad. Sci. USA, 92 (1995) 8274-8278.
66. [66] Tresco, P.A., Winn, S.R., Tan, S., Jaeger, C.B., Greene, L.A. and Aebischer P., Polymer-encapsulated PC12 cells: long-term survival and associated reduction in lesion-induced rotational behavior, Cell Transplant., 1 (1992) 255-264.
67. [67] Wallace, J.E., Krauter, E.E. and Campbell, B.A., Motor and reflexive behavior in the aging rat, J. Gerontol., 35 (1980) 364-370.
68. [68] Willig, F., Palacios, A., Monmaur, P., M'Harzi, M., Laurent, J. and Delacour, J., Short-term memory, exploration and locomotor activity in aged rats, Neurobiol. Aging, 8 (1987) 393-402.
69. [69] Winn, S.R., Tresco, P.A., Zielinski, B., Greene, L.A., Jaeger, C.B. and Aebischer, P., Behavioral recovery following intrastriatal implantation of microencapsulated PC12 cells, Exp. Neurol., 113 (1991) 22-329.
70. [70] Winn, S.R., Hammang, J.P., Emerich, D.F., Lee, A., Palmiter, R.D. and Baetge, E.E., Polymer-encapsulated cells genetically modified to secrete human nerve growth factor promote the survival of axotomized septal cholinergic neurons, Proc. Natl. Acad. Sci. USA, 91 (1994) 2324-2328.
71. [71] Winn, S.R., Lindner, M.D., Haggett, G., Francis, J.M. and Emerich, D.F., Polymer-encapsulated genetically-modified cells continue to secrete human nerve growth factor for over one year in rat ventricles:behavioral and anatomical consequences, Exp. Neurol., in press.
72. [72] Wong, D.F., Wagner, H.N., Dannals, R.F., Links J.M., Frost, J.J., Ravert, H.T., Wilson, A.A., Rosenbaum, A.E., Gjedde, A., Douglass, K.H., Petronis J.D., Folstein, M.F., Toung, J.K.T., Burns, H.D. and Kuhar M.J., Effects of age on dopamine and serotonin receptors measured by positron tomography in the living human brain, Science, 226 (1984) 1393-1396.